Table of Contents
Volume 3 | Issue 4
Publication Date: February 2004
Abstract
No Access
Pay-Per View
Full Text
Add to Cart
Editorial | ||
 205 |
Cetuximab Targeted Therapy: A New Treatment Paradigm for Advanced Colorectal Cancer Edward Chu |
|
Research in Brief | ||
211-214 |
Update on Adjuvant Trials in the Treatment of High-Risk Colorectal Cancer Kavita Maung, Edward Chu, Vinay K. Jain |
|
Comprehensive Review | ||
215-222 |
Ovarian Neoplasms in Patients with Colorectal Cancer: Understanding the Role of Prophylactic Oophorectomy Nader N. Hanna, Alfred M. Cohen |
|
Commentary | ||
223-224 |
Biologic Basis of Ovarian Metastasis of Colorectal Cancer Romano Danesi, Guido Bocci, Antonello Di Paolo |
|
Original Contributions | ||
225-234 |
Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Polymorphisms and Their Association with 5-Fluorouracil/Leucovorin Chemotherapy in Colorectal Cancer Andrew X. Zhu, Thomas A. Puchalski, Vincent P. Stanton, Jr, David P. Ryan, Jeffrey W. Clark, Steven Nesbitt, Olga Charlat, Patrick Kelly, Elaine Kreconus, Bruce A. Chabner, Jeffrey G. Supko |
|
235-242 |
Phase III Study of Mitomycin-C with Protracted Venous Infusion or Circadian-Timed Infusion of 5-Fluorouracil in Advanced Colorectal Carcinoma Timothy J. Price, Paul J. Ross, Tamas Hickish, Diana Tait, Andy R. Norman, Hugo E.R. Ford, Gary Middleton, Kate Sumpter, Mark Hill, Jacqui Oates, David Cunningham |
|
Imaging in Colorectal Cancer | ||
243-247 |
Cyclooxygenase-2 Expression in Right- and Left-Sided Colon Cancer: A Rationale For Optimization of Cyclooxygenase-2 Inhibitor Therapy Aejaz Nasir, Hans E. Kaiser, David Boulware, Ardeshir Hakam, Helena Zhao, Timothy Yeatman, James Barthel, Domenico Coppola |
|
